Semax & Selank appears in research contexts involving anxiolytic pathway research, neuropeptide models, immune-neural signaling studies
mRNA expression of transporters and junctional protein localization at membrane sites in iPSC-derived endothelial cells are further useful indices (Delsing et al., 2008)
In skeletal muscle specifically, MOTS-c has been shown to enhance glucose transporter-4 (GLUT4) translocation to the cell surface, the molecular mechanism by which muscle cells absorb glucose from the bloodstream
In some embodiments, the otic formulation or composition contains at least one viscosity modulating agent that provides the otic formulation or composition with a viscosity of at least about 10 cP, about 20 cP, about 30 cP, about 40 cP, about 50 cP, about 60 cP, about 70 cP, about 80 cP, about 90 cP, about 100 cP, about 200 cP, about 300 cP, about 400 cP, about 500 cP, about 600 cP, about 700 cP, about 800 cP, about 900 cP, about 1000 cP, about 2,000 cP, about 3,000 cP, about 4,000 cP, about 5,000 cP, about 6,000 cP, about 7,000 cP, about 8,000 cP, about 9,000 cP, about 10,000 cP, about 15,000 cP, or about 20,000 cP
Acknowledgements This work was financially supported by the German Research Foundation (Collaborative Research Centre 1112, Project C02 to MSK, C05 to JL, and Z01 to NM, MSK, and BK
